Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone in Breast Cancer with Brain Metastases
NCT00496379Phase 2Terminated
- Sponsor
- Nancy Lin
- Start
- Jul 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sagopilone in breast cancer, sponsored by Nancy Lin. Primary endpoint: Objective Response Rate in the Central Nervous System at 2 years. Started Jul 2007; status: terminated.
02
Drugs
sagopilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00496379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496379.